South Africa's laboratory medicine sector is experiencing significant growth, driven by the country's expanding hospital infrastructure and increasing demand for faster and more accurate diagnostic services. The sector is witnessing strong commercial and clinical momentum, with a rising need for automation, advanced diagnostic platforms, and point-of-care testing. This growth is supported by the country's large and sophisticated laboratory network.
The South African healthcare providers market was valued at US$40.3 million in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 3.8% to US$48.7 million by 2029, according to a 2025 GlobalData/MarketLine industry profile. This projected growth provides a solid anchor for sustained investment in the sector over several years. The expansion of hospital infrastructure in both public and private sectors is reinforcing the scale-up of laboratory services.
The World Health Expo (WHX) 2026, scheduled to take place in Johannesburg from 6-8 October, will bring together leaders in laboratory medicine, hospital infrastructure executives, procurement specialists, and healthcare investors. The event, held at the Gallagher Convention Centre, will feature a dedicated Laboratory Zone and the National Health Laboratory Service (NHLS)-partnered Lab Leadership Indaba. These platforms will enable decision-makers to evaluate technologies, partnerships, and investment opportunities shaping the sector's growth.
Prof Koleka Mlisana, Chief Executive Officer of the NHLS, highlighted that demand for laboratory services in South Africa is outpacing historical baselines. This is driven by hospital network expansion, chronic disease burden, and the need for faster and more accurate turnaround times. Mlisana emphasized that laboratory capacity is no longer a back-office function but is central to clinical decision-making, patient flow, and hospital throughput.
The Laboratory Zone at WHX will be dedicated to lab automation, diagnostics, and point-of-care suppliers. The wider exhibition will feature over 10,000 attendees and 600 exhibitors from more than 60 countries. This will provide a platform for suppliers and healthcare decision-makers to connect and explore opportunities in the sector. Tom Coleman, Portfolio Director – Healthcare, inD, organiser of WHX, noted that market signals indicate investment is flowing into laboratory and diagnostics infrastructure due to its proven clinical and operational value.
Coleman further stated that suppliers and investors are evaluating market entry and expansion based on demonstrated demand, hospital network growth, and the need for faster and decentralized testing. The growth of the laboratory medicine sector in South Africa is driven by the need for efficient and effective diagnostic services. The sector's expansion is expected to have a positive impact on the country's healthcare system.
The World Health Expo 2026 in Johannesburg is set to provide a platform for stakeholders to discuss the future of laboratory medicine in South Africa. With a focus on laboratory automation, diagnostics, and point-of-care testing, the event aims to facilitate collaboration and investment in the sector. Key stakeholders, including laboratory medicine leaders and hospital infrastructure executives, will come together to shape the sector's next phase of growth.
Key points
- The South African laboratory medicine sector is expected to grow due to hospital infrastructure expansion and rising demand for automation and advanced diagnostic platforms.
- The World Health Expo 2026 will bring together laboratory medicine leaders, hospital infrastructure executives, and healthcare investors to discuss the sector's growth.
- The sector's growth is driven by the need for efficient and effective diagnostic services, with laboratory capacity becoming central to clinical decision-making.
